Insights
![](https://www.wcgclinical.com/wp-content/uploads/2020/06/w-320-3.jpg)
COVID-19
Part 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/06/remote-nurse-assessment.jpg)
Hybrid & Decentralized Trials
What are the regulations for training home health individuals who are working remotely to collect study data?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/05/doctor-consent-form-elderly-patient.jpg)
Series: Ask the IRB & IBC Experts
Should Consent Form updates be aligned with Investigator Brochure updates, or wait for next Protocol amendment?
Blog Posts![](https://www.wcgclinical.com/wp-content/uploads/2020/05/d589f5875bf277d4301947cece3389a3.jpg)
COVID-19
PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects
Videos![](https://www.wcgclinical.com/wp-content/uploads/2020/05/f4b8b84e62feb71c427cd061e624b516.jpg)
COVID-19
PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines
Videos![](https://www.wcgclinical.com/wp-content/uploads/2022/03/bringing-clinical-trials-closer-to-home-smaller-local-sites-build-trust-provide-access-to-local-communities.jpeg)
Series: WCG Patient Radio
Dolly Niles: Bringing Clinical Trials Closer to Home: Smaller, Local Sites Build Trust & Provide Access to Local Communities
Podcasts![](https://www.wcgclinical.com/wp-content/uploads/2020/05/w-320-7.jpg)
COVID-19
Part 8: The Realities of Restart
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/05/w-320-6.jpg)
COVID-19
Part 7: Imagining the Future State of Clinical Research
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/05/w-320-5.jpg)
COVID-19
Part 6: Going Remote During COVID-19: Considerations When Moving Studies Out of the Clinic Setting
Whitepapers![](https://www.wcgclinical.com/wp-content/uploads/2020/05/w-320-4.jpg)
COVID-19